Cas:6403-17-4 H-Ser-Ala-OH manufacturer & supplier

We serve Chemical Name:H-Ser-Ala-OH CAS:6403-17-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

H-Ser-Ala-OH

Chemical Name:H-Ser-Ala-OH
CAS.NO:6403-17-4
Synonyms:serylalanine;Serinyl-Alanine;L-Alanine,L-seryl;N-L-seryl-L-alanine;L-seryl-L-alanine;L-Ser-L-Ala
Molecular Formula:C6H12N2O4
Molecular Weight:176.17000
HS Code:2924199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:112.65000
Exact Mass:176.08000
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like serylalanine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-Ser-L-Ala physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,serylalanine Use and application,L-Ser-L-Ala technical grade,usp/ep/jp grade.


Related News: As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. H-Ser-Ala-OH manufacturer Government officials say that the number of visitors from the mainland and other countries has decreased significantly after they closed several border points and rail stations and cut flight arrivals by half. H-Ser-Ala-OH supplier Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees. H-Ser-Ala-OH vendor As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. H-Ser-Ala-OH factory The rest of South Korea will also consider stopping issuing tourist visas to Chinese nationals, said Park Neung-hoo, the government��s minister of health and welfare. All travelers from China will be separated from the other arrivals for heightened screening at airports.